Sort
21,453 grants matching “tuberculosis”
Infectious Diseases Training program in Bolivia: South-South Training with Peru
$213,353Robert H Gilman · Johns Hopkins University · D43 · FY2019 · TW
Rapid Breath-Based Diagnosis of Histoplasmosis
$213,288Sophia Koo · Brigham And Women'S Hospital · R21 · FY2018 · AI
Mali International Center for Excellence in Research: Filariasis
$213,240Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIS
$213,200Ferric C Fang · University Of Washington · T32 · FY2017 · AI
Crystallization of the Galactosyltransferase from Mtb
$213,166Southern Research Institute · R21 · FY2002 · AI
Vaccination strategies against pulmonary tuberculosis
$213,000Louisiana State Univ Hsc New Orleans · R01 · FY2004 · AI
Vaccination strategies against pulmonary tuberculosis
$213,000Louisiana State Univ Hsc New Orleans · R01 · FY2005 · AI
Tubercle Bacilli Binding to Host Cells: Vaccine Design
$212,987Ligocyte Pharmaceuticals, Inc. · R41 · FY2002 · AI
Genomics Training and Career Development for African Scientists
$212,925Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2020 · AI
A pipeline for prioritizing and evaluating multidrug regimens for Mycobacterium abscessus
$212,873Rafael E Hernandez · Seattle Children'S Hospital · R21 · FY2020 · AI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors
$212,843Eric Joseph Rubin · Texas A&M University · U01 · FY2011 · GM
Patient-Oriented Substance Use/Smoking Cessation Research in HIV Treatment and Prevention
$212,818Conall Michael O'Cleirigh · Massachusetts General Hospital · K24 · FY2025 · DA
Patient-Oriented Substance Use/Smoking Cessation Research in HIV Treatment and Prevention
$212,818Conall Michael O'Cleirigh · Massachusetts General Hospital · K24 · FY2024 · DA
Glutamine metabolism in tuberculosis
$212,704Lanbo Shi · Rbhs-New Jersey Medical School · R21 · FY2021 · AI
Characterizing CaeA-mediated rifampin tolerance in MTB
$212,621Petros C Karakousis · Johns Hopkins University · R21 · FY2024 · AI
In Host Evolution of Nontuberculous Mycobacteria in Cystic Fibrosis
$212,584Paul J Planet · Children'S Hosp Of Philadelphia · R21 · FY2021 · AI
SPATIO-TEMPORAL EPIDEMIOLOGY: METHODS AND APPLICATIONS
$212,562Jonathan C Wakefield · University Of Washington · R01 · FY2017 · CA
SPATIO-TEMPORAL EPIDEMIOLOGY: METHODS AND APPLICATIONS
$212,562Jonathan C Wakefield · University Of Washington · R01 · FY2015 · CA
SPATIO-TEMPORAL EPIDEMIOLOGY: METHODS AND APPLICATIONS
$212,562Jonathan C Wakefield · University Of Washington · R01 · FY2016 · CA
Discovering novel antifungal agents via multi-species profiling of a structurally and stereochemically diverse, well-validated compound library
$212,512Partha Pratim Nag · Broad Institute, Inc. · R21 · FY2020 · AI
Placental determinants of neonatal immune function in maternal HIV infection
$212,510Jyoti S Mathad · Weill Medical Coll Of Cornell Univ · R21 · FY2020 · HD
Role of Lipid Antigen-Specific T Cells in the Anti-mycobacterial Immune Response of BCG/SIV Infected Macaques
$212,500Namita Rout · Tulane University Of Louisiana · R21 · FY2019 · AI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program
$212,437Spyros A Kalams · Vanderbilt University · T32 · FY2012 · AI
Live Oral Listeria Vaccine Vector
$212,373Paul Edwin Orndorff · North Carolina State University Raleigh · R21 · FY2010 · AI
Antibiotic tolerance as a stepping stone to tuberculosis drug-resistance
$212,350Babak Javid · University Of California, San Francisco · R21 · FY2023 · AI